The Development of Coronary Artery Stents: From Bare-Metal to Bio-Resorbable Types

Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents

(2016) Xin-Lin Zhang et al.   ANNALS OF INTERNAL MEDICINE

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents

(2016) Lisette Okkels Jensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

(2016) Michael Haude et al.   LANCET

Biodegradable Metals for Cardiovascular Stents: from Clinical Concerns to Recent Zn-Alloys

(2016) Patrick K. Bowen et al.   Advanced Healthcare Materials

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

(2015) Bent Raungaard et al.   LANCET

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

(2015) Patrick W Serruys et al.   LANCET

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

(2015) Stephen G. Ellis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial

(2015) Georgios J. Vlachojannis et al.   EuroIntervention

Long-Term Clinical Outcomes After Everolimus- and Sirolimus-Eluting Coronary Stent Implantation

(2014) Hiroki Shiomi et al.   Circulation-Cardiovascular Interventions

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial

(2014) S. Saito et al.   EUROPEAN HEART JOURNAL

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

(2014) Thomas Pilgrim et al.   LANCET

New stent surface materials: The impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets

(2013) Raila Busch et al.   Acta Biomaterialia

Parameters of Endothelial Function are Dependent on Polymeric Surface Material

(2013) R Busch et al.   Biomedical Engineering-Biomedizinische Technik

The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent

(2013) Ajay J. Kirtane et al.   JACC-Cardiovascular Interventions

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

(2013) Patrick W. Serruys et al.   JACC-Cardiovascular Interventions

A Next-Generation Bioresorbable Coronary Scaffold System: From Bench to First Clinical Evaluation

(2013) Stefan Verheye et al.   JACC-Cardiovascular Interventions

Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent

(2013) Masahiro Natsuaki et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

(2013) Michael Haude et al.   LANCET

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

(2013) Pieter Cornelis Smits et al.   LANCET

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

(2013) Evald Høj Christiansen et al.   LANCET

Lesion Length Impacts Long Term Outcomes of Drug-Eluting Stents and Bare Metal Stents Differently

(2013) Shang-Hung Chang et al.   PLoS One

Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: Final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TES

(2012) Lamin King et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

(2012) Sripal Bangalore et al.   CIRCULATION

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials

(2012) G. G. Stefanini et al.   EUROPEAN HEART JOURNAL

Primary Endpoint Results of the EVOLVE Trial

(2012) Ian T. Meredith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions

(2012) Didier Carrié et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

(2012) Clemens von Birgelen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

(2012) Manel Sabate et al.   LANCET

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

(2012) Edoardo Camenzind et al.   LANCET

Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design

(2012) Lorenz Räber et al.   EuroIntervention

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

(2012) Dariusz Dudek et al.   EuroIntervention

Polymer-Free Sirolimus- and Probucol-Eluting Versus New Generation Zotarolimus-Eluting Stents in Coronary Artery Disease

(2011) Steffen Massberg et al.   CIRCULATION

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents

(2011) David E. Kandzari et al.   JACC-Cardiovascular Interventions

Polymer-Free Biolimus A9-Coated Stent Demonstrates More Sustained Intimal Inhibition, Improved Healing, and Reduced Inflammation Compared With a Polymer-Coated Sirolimus-Eluting Cypher Stent in a Porcine Model

(2010) Norio Tada et al.   Circulation-Cardiovascular Interventions

Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization

(2010) Duk-Woo Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

(2010) Elvin Kedhi et al.   LANCET

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

(2010) Gregg W. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

(2010) Christoph Kaiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

(2010) Patrick W. Serruys et al.   NEW ENGLAND JOURNAL OF MEDICINE

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

(2010) Patrick Serruys et al.   EuroIntervention

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

(2009) R. A. Byrne et al.   EUROPEAN HEART JOURNAL

A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents

(2009) Philip Moore et al.   JACC-Cardiovascular Interventions

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

(2009) Patrick W Serruys et al.   LANCET

Observations and Outcomes of Definite and Probable Drug-Eluting Stent Thrombosis Seen at a Single Hospital in a Four-Year Period

(2008) Tina L. Pinto Slottow et al.   AMERICAN JOURNAL OF CARDIOLOGY

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease

(2008) Mitchell W. Krucoff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Late Stent Recoil of the Bioabsorbable Everolimus-Eluting Coronary Stent and its Relationship With Plaque Morphology

(2008) Shuzou Tanimoto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY